148 related articles for article (PubMed ID: 36678822)
1. Efficacy and Safety Evaluation of Mometasone Furoate in Treating Ocular Inflammation.
Lage NA; de Paiva MRB; Vasconcelos-Santos DV; Machado RR; Fialho SL; Silva-Cunha A
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678822
[TBL] [Abstract][Full Text] [Related]
2. Licarin A as a Novel Drug for Inflammatory Eye Diseases.
Paiva MRB; Vasconcelos-Santos DV; Coelho MM; Machado RR; Lopes NP; Silva-Cunha A; Fialho SL
J Ocul Pharmacol Ther; 2021 Jun; 37(5):290-300. PubMed ID: 33761287
[No Abstract] [Full Text] [Related]
3. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
Noonan M; Leflein J; Corren J; Staudinger H
BMC Pediatr; 2009 Jul; 9():43. PubMed ID: 19594937
[TBL] [Abstract][Full Text] [Related]
4. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
Karpel JP; Nelson H
Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal thalidomide ameliorates inflammation in a model of experimental uveitis induced by BCG.
Castro BFM; Vieira LC; Vasconcelos-Santos DV; Cenachi SPF; Cotta OAL; Guerra MCA; Paiva MRB; Silva LM; Silva-Cunha A; Fialho SL
Int Immunopharmacol; 2020 Apr; 81():106129. PubMed ID: 32018067
[TBL] [Abstract][Full Text] [Related]
6. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
Daley-Yates PT; Deans A; Mehta R; Sousa AR
Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone furoate is more effective than mometasone furoate in restoring tobacco smoke inhibited SOCS-3 expression in airway epithelial cells.
Nasreen N; Gonzalves L; Peruvemba S; Mohammed KA
Int Immunopharmacol; 2014 Mar; 19(1):153-60. PubMed ID: 24434372
[TBL] [Abstract][Full Text] [Related]
9. Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis.
Moreira Castro BF; Nunes da Silva C; Barbosa Cordeiro LP; Pereira de Freitas Cenachi S; Vasconcelos-Santos DV; Machado RR; Dias Heneine LG; Silva LM; Silva-Cunha A; Fialho SL
Curr Res Pharmacol Drug Discov; 2022; 3():100107. PubMed ID: 35647524
[TBL] [Abstract][Full Text] [Related]
10. Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids.
Weinstein SF; Corren J; Murphy K; Nolte H; White M;
Allergy Asthma Proc; 2010; 31(4):280-9. PubMed ID: 20687982
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.
Bousquet J; D'Urzo A; Hebert J; Barraza CH; Boulet LP; Suárez-Chacón R; Harnest U; Lundbäck B; Martinez Morales G; Nieminen MM; Nolop KB; Visser S; Lutsky BN
Eur Respir J; 2000 Nov; 16(5):808-16. PubMed ID: 11153576
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X
Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma.
Maspero JF; Nolte H; Chérrez-Ojeda I;
J Asthma; 2010 Dec; 47(10):1106-15. PubMed ID: 20874458
[TBL] [Abstract][Full Text] [Related]
14. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids.
Nathan RA; Nolte H; Pearlman DS;
Allergy Asthma Proc; 2010; 31(4):269-79. PubMed ID: 20678306
[TBL] [Abstract][Full Text] [Related]
15. Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study.
van Zyl-Smit RN; Krüll M; Gessner C; Gon Y; Noga O; Richard A; de Los Reyes A; Shu X; Pethe A; Tanase AM; D'Andrea P;
Lancet Respir Med; 2020 Oct; 8(10):987-999. PubMed ID: 32653075
[TBL] [Abstract][Full Text] [Related]
16. One-year treatment with mometasone furoate in chronic obstructive pulmonary disease.
Calverley PM; Rennard S; Nelson HS; Karpel JP; Abbate EH; Stryszak P; Staudinger H
Respir Res; 2008 Nov; 9(1):73. PubMed ID: 19014549
[TBL] [Abstract][Full Text] [Related]
17. A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma.
Weinstein CLJ; Gates D; Zhang X; Varnell T; Mok W; Vermeulen JH; Amar NJ; Jain N
Pediatr Pulmonol; 2020 Apr; 55(4):882-889. PubMed ID: 32022483
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma.
Buhl R; Tanase AM; Hosoe M; Cao W; Demin I; Bartels C; Jauernig J; Ziegler D; Patalano F; Hederer B; Kanniess F; Tillmann HC
Pulm Pharmacol Ther; 2020 Jun; 62():101919. PubMed ID: 32387408
[TBL] [Abstract][Full Text] [Related]
19. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
[TBL] [Abstract][Full Text] [Related]
20. The therapeutic efficacy of mometasone furoate cream 0.1% applied once daily vs clobetasol propionate cream 0.05% applied twice daily in chronic eczema.
Goh CL; Lim JT; Leow YH; Ang CB; Kohar YM
Singapore Med J; 1999 May; 40(5):341-4. PubMed ID: 10489492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
